These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34651184)

  • 1. Reducing the Risk of Withdrawal Symptoms and Relapse Following Clozapine Discontinuation-Is It Feasible to Develop Evidence-Based Guidelines?
    Blackman G; Oloyede E; Horowitz M; Harland R; Taylor D; MacCabe J; McGuire P
    Schizophr Bull; 2022 Jan; 48(1):176-189. PubMed ID: 34651184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal.
    Shiovitz TM; Welke TL; Tigel PD; Anand R; Hartman RD; Sramek JJ; Kurtz NM; Cutler NR
    Schizophr Bull; 1996; 22(4):591-5. PubMed ID: 8938913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine Combination and Augmentation Strategies in Patients With Schizophrenia -Recommendations From an International Expert Survey Among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group.
    Wagner E; Kane JM; Correll CU; Howes O; Siskind D; Honer WG; Lee J; Falkai P; Schneider-Axmann T; Hasan A;
    Schizophr Bull; 2020 Dec; 46(6):1459-1470. PubMed ID: 32421188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine dose for schizophrenia.
    Subramanian S; Völlm BA; Huband N
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD009555. PubMed ID: 28613395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supersensitivity psychosis in a case with clozapine tolerance.
    Ozcan S; Soydan A; Tamam L
    Eur Rev Med Pharmacol Sci; 2012 Oct; 16 Suppl 4():70-3. PubMed ID: 23090814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing clozapine discontinuation - acute and chronic maintenance strategies.
    Shields MK; Bastiampillai T; Mohan T
    Aust N Z J Psychiatry; 2012 Nov; 46(11):1104-5. PubMed ID: 23104931
    [No Abstract]   [Full Text] [Related]  

  • 7. Clozapine withdrawal-emergent dystonias and dyskinesias: a case series.
    Ahmed S; Chengappa KN; Naidu VR; Baker RW; Parepally H; Schooler NR
    J Clin Psychiatry; 1998 Sep; 59(9):472-7. PubMed ID: 9771818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of Antipsychotic Use After Clozapine Discontinuation: A Real-World Study Across Antipsychotics.
    Stam N; Taipale H; Tanskanen A; Isphording L; Okhuijsen-Pfeifer C; Schuiling-Veninga CCM; Bos JHJ; Bijker BJ; Tiihonen J; Luykx JJ
    Clin Transl Sci; 2020 Nov; 13(6):1170-1177. PubMed ID: 32441836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine levels after clozapine discontinuation.
    de Leon J; Henighan V; Stanilla JK; Simpson GM
    J Clin Psychopharmacol; 1996 Apr; 16(2):193-4. PubMed ID: 8690839
    [No Abstract]   [Full Text] [Related]  

  • 10. Switching patients from clozapine to risperidone therapy.
    Zimbroff DL
    Am J Psychiatry; 1995 Jul; 152(7):1102. PubMed ID: 7540802
    [No Abstract]   [Full Text] [Related]  

  • 11. Recurrent clozapine and lorazepam withdrawal psychosis with catatonia.
    Wang BZ; Gupta A; Bastiampillai T; Sani F
    Aust N Z J Psychiatry; 2012 Aug; 46(8):795-6. PubMed ID: 22495953
    [No Abstract]   [Full Text] [Related]  

  • 12. [No rebound psychosis in a case of switching from clozapine to quetiapine].
    Walther S; Baciu D
    Psychiatr Prax; 2006 Mar; 33(2):93-4. PubMed ID: 16502388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe extrapyramidal side effects when discontinuing clozapine and starting haloperidol.
    Bobba R
    Can J Psychiatry; 1997 Jun; 42(5):530. PubMed ID: 9220119
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clozapine withdrawal. A review].
    Szafrański T; Gmurkowski K
    Psychiatr Pol; 1999; 33(1):51-67. PubMed ID: 10786215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse following clozapine withdrawal: effect of neuroleptic drugs and cyproheptadine.
    Meltzer HY; Lee MA; Ranjan R; Mason EA; Cola PA
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):176-87. PubMed ID: 8935814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Off-Label Use of Clozapine in Children and Adolescents-A Literature Review.
    Rachamallu V; Elberson BW; Vutam E; Aligeti M
    Am J Ther; 2019; 26(3):e406-e416. PubMed ID: 31082865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine-withdrawal catatonia.
    Wadekar M; Syed S
    Psychosomatics; 2010; 51(4):355-355.e2. PubMed ID: 20587767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.
    Barber S; Olotu U; Corsi M; Cipriani A
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD006324. PubMed ID: 28333365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does adding a second antipsychotic to clozapine improve clinical response in resistant schizophrenia?
    Jiménez-Cornejo M; Munizaga G; Aceituno D
    Medwave; 2016 Dec; 16(Suppl5):e6614. PubMed ID: 27922589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the Effect of the Changes in FDA Guidelines for Clozapine Monitoring.
    Sultan RS; Olfson M; Correll CU; Duncan EJ
    J Clin Psychiatry; 2017; 78(8):e933-e939. PubMed ID: 28742291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.